Literature DB >> 29164439

Brief Report: Major Depressive Disorder with Psychotic Features in Williams Syndrome: A Case Series.

Francisca Valdes1, Christopher J Keary2,3, Jennifer E Mullett2, Michelle L Palumbo2,3, Jessica L Waxler4, Barbara R Pober4,3, Christopher J McDougle5,6.   

Abstract

Descriptions of individuals with Williams syndrome (WS) and co-morbid major depressive disorder (MDD) with psychotic features have not appeared in the literature. In addition to reviewing previous reports of psychotic symptoms in persons with WS, this paper introduces clinical histories and therapeutic management strategies for three previously unreported adults with WS diagnosed with co-morbid MDD with psychotic features. Co-morbid medical disorders common in WS are highlighted with regard to safe and appropriate pharmacological treatment. The importance of assessment for co-morbid MDD with psychotic features in individuals with WS is emphasized.

Entities:  

Keywords:  Co-morbidity; Major depressive disorder; Psychopharmacology; Psychosis; Williams syndrome

Mesh:

Year:  2018        PMID: 29164439     DOI: 10.1007/s10803-017-3384-x

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  18 in total

1.  High prevalence of diabetes and pre-diabetes in adults with Williams syndrome.

Authors:  B R Pober; E Wang; S Caprio; K F Petersen; C Brandt; T Stanley; L R Osborne; J Dzuria; B Gulanski
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-05-15       Impact factor: 3.908

2.  Development of erosive gastrointestinal lesions during risperidone treatment in two patients with Williams syndrome.

Authors:  Valeria Savoja; Stefano Vicari
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-03-19       Impact factor: 5.067

3.  Mental health problems in adults with Williams syndrome.

Authors:  Chris Stinton; Sarah Elison; Patricia Howlin
Journal:  Am J Intellect Dev Disabil       Date:  2010-01

Review 4.  Metabolic monitoring for patients treated with antipsychotic medications.

Authors:  Tony A Cohn; Michael J Sernyak
Journal:  Can J Psychiatry       Date:  2006-07       Impact factor: 4.356

5.  Williams' syndrome in adulthood: a case study focusing on psychological and psychiatric aspects.

Authors:  E A Bradley; O Udwin
Journal:  J Ment Defic Res       Date:  1989-04

6.  A comparative study of the neuropsychiatric and neurocognitive phenotype in two microdeletion syndromes: velocardiofacial (22q11.2 deletion) and Williams (7q11.23 deletion) syndromes.

Authors:  O Zarchi; A Diamond; R Weinberger; D Abbott; M Carmel; A Frisch; E Michaelovsky; R Gruber; T Green; A Weizman; D Gothelf
Journal:  Eur Psychiatry       Date:  2013-09-17       Impact factor: 5.361

7.  Prevalence estimation of Williams syndrome.

Authors:  Petter Strømme; Per G Bjørnstad; Kjersti Ramstad
Journal:  J Child Neurol       Date:  2002-04       Impact factor: 1.987

Review 8.  Risk of sudden death in the Williams-Beuren syndrome.

Authors:  Armin Wessel; Verena Gravenhorst; Reiner Buchhorn; Angela Gosch; Carl-Joachim Partsch; Rainer Pankau
Journal:  Am J Med Genet A       Date:  2004-06-15       Impact factor: 2.802

9.  Almost all antipsychotics result in weight gain: a meta-analysis.

Authors:  Maarten Bak; Annemarie Fransen; Jouke Janssen; Jim van Os; Marjan Drukker
Journal:  PLoS One       Date:  2014-04-24       Impact factor: 3.240

10.  QT interval and antidepressant use: a cross sectional study of electronic health records.

Authors:  Victor M Castro; Caitlin C Clements; Shawn N Murphy; Vivian S Gainer; Maurizio Fava; Jeffrey B Weilburg; Jane L Erb; Susanne E Churchill; Isaac S Kohane; Dan V Iosifescu; Jordan W Smoller; Roy H Perlis
Journal:  BMJ       Date:  2013-01-29
View more
  2 in total

1.  Psychotic Symptoms and Malignant Neuroleptic Syndrome in Williams Syndrome: A Case Report.

Authors:  Boris Karpov; Maria Muhonen; Tuula Kieseppä
Journal:  Front Psychiatry       Date:  2022-05-31       Impact factor: 5.435

2.  Psychiatric illness and regression in individuals with Phelan-McDermid syndrome.

Authors:  Teresa M Kohlenberg; M Pilar Trelles; Brittany McLarney; Catalina Betancur; Audrey Thurm; Alexander Kolevzon
Journal:  J Neurodev Disord       Date:  2020-02-12       Impact factor: 4.025

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.